Medication info
Jobatorin Tablet 10/20 mg (Ezetimibe / Simvastatin)

Jobatorin Tablet 10/20 mg (Ezetimibe / Simvastatin)

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
KIPS Biopharma Co., Ltd.
Appearance
White to off-white, bilaterally convex, rectangular tablet
Packaging
30 Tablets (10 Tablets/ Blister Pack x 3)
Approval status
Active

MFDS item code 201601385 · Approved 2016.03.09 · Insurance code 693202700

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dosage of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, regardless of meals. Patients with primary hypercholesterolemia The dosage range of this medicine is 10/10mg~10/40mg once daily. The generally recommended initial dosage is 10/20mg once daily. Patients who require a smaller reduction in LDL cholesterol may start with 10/10mg once daily. After initiating treatment or adjusting the dosage, check blood lipid levels at intervals of at least 4 weeks before adjusting the dosage. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or more without evidence of muscle toxicity (see section 1, Warnings, under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dosage for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see section 5, General Precautions, subsection Patients with Abnormal Liver Function, under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. When administering higher doses of this medicine to these patients, use caution and monitor them closely (see section 5, General Precautions, under Precautions for Use). Administration to elderly patients No dosage adjustment is necessary for elderly patients. Concomitant administration with other medicines (See section 6, Interactions, under Precautions for Use.) Administer this medicine at least 2 hours before or 4 hours after a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Ingredients

Manufacturer
KIPS Biopharma Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated ApoB protein
  • elevated triglycerides
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia
View approved original text

This medication is used in conjunction with dietary therapy to lower cholesterol and triglyceride levels in patients with primary hypercholesterolemia, including familial or non-familial hypercholesterolemia, as well as mixed hyperlipidemia, while increasing levels of good cholesterol (HDL). It is also administered as an adjunct or alternative treatment for patients with homozygous familial hypercholesterolemia to effectively control blood cholesterol levels. This medication helps improve lipid levels in patients at risk of atherosclerotic vascular disease due to hypercholesterolemia. Prior to treatment, secondary causes such as diabetes or hypothyroidism should be identified and treated if necessary, and this medication is used when responses to dietary modifications and non-drug therapies are insufficient. Regular monitoring of total cholesterol, LDL, HDL, and triglyceride levels is advised, particularly using accurate measurement methods when triglycerides are elevated. This medication plays a positive role in preventing cardiovascular disease and improving lipid abnormalities.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dosage of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, regardless of meals. Patients with primary hypercholesterolemia The dosage range of this medicine is 10/10mg~10/40mg once daily. The generally recommended initial dosage is 10/20mg once daily. Patients who require a smaller reduction in LDL cholesterol may start with 10/10mg once daily. After initiating treatment or adjusting the dosage, check blood lipid levels at intervals of at least 4 weeks before adjusting the dosage. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or more without evidence of muscle toxicity (see section 1, Warnings, under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dosage for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see section 5, General Precautions, subsection Patients with Abnormal Liver Function, under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. When administering higher doses of this medicine to these patients, use caution and monitor them closely (see section 5, General Precautions, under Precautions for Use). Administration to elderly patients No dosage adjustment is necessary for elderly patients. Concomitant administration with other medicines (See section 6, Interactions, under Precautions for Use.) Administer this medicine at least 2 hours before or 4 hours after a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Precautions

This medication is used to lower cholesterol levels in the blood. Caution is required as muscle-related problems such as myalgia or muscle weakness may occur when taking this medication. In particular, the risk of muscle damage may be higher when taken in high doses, so consult a physician immediately if any abnormal symptoms arise. Patients with liver dysfunction or liver disease should avoid taking this medication. Pregnant or nursing women should also not use this medication. Furthermore, this medication may interact with other drugs, so it is essential to inform healthcare providers about any medications currently being taken. Especially, taking it with certain antibiotics, antifungals, immunosuppressants, or antivirals may increase the risk of muscle damage. It is advisable to regularly monitor liver function and muscle enzyme levels through blood tests while taking this medication. Elderly patients may respond more sensitively to this medication, so caution is necessary during use. Lastly, immediately inform a physician if unexplained muscle pain or weakness occurs during treatment, and do not discontinue the medication without following the healthcare provider's instructions.

Side effects

  • Myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory tract infection
  • myalgia
  • limb pain
  • fatigue
Show 106 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • elevated creatine phosphokinase
  • increased liver aminotransferase levels
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • sensory disturbance
  • depression
  • cholelithiasis
  • cholecystitis
  • epidermal necrolysis
  • toxic epidermal necrolysis
  • eosinophilia
  • drug response with systemic symptoms
  • erythema multiforme
  • drug-induced liver damage
  • myasthenia
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • muscle cramps
  • immune-mediated necrotizing myopathy
  • specific cranial nerve dysfunction
  • taste disturbance
  • ocular motility disorders
  • facial paresis
  • tremor
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorder
  • anxiety
  • sleep disorder
  • memory impairment
  • amnesia
  • memory loss
  • cognitive impairment
  • confusion
  • interstitial lung disease
  • angioedema
  • lupus-like erythema
  • polymyalgia rheumatica
  • dermatomyositis
  • vasculitis
  • purpura
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • arthritis
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • cholestatic jaundice
  • liver fat changes
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • liver failure
  • alopecia
  • various skin changes
  • lichen planus-like drug rash
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • increased ALP
  • elevated γ-GT
  • increased bilirubin levels
  • thyroid dysfunction
  • increased HbA1c
  • increased fasting blood glucose levels
  • edema
  • thirst
  • facial edema
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucous stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a sealed container. It is best to maintain storage temperatures between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White to off-white, bilaterally convex, rectangular tablet

Package unit

30 Tablets (10 Tablets/ Blister Pack x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.